Portfolio item number 1
Short description of portfolio item number 1
Posts by Collection
portfolio
Portfolio item number 2
Short description of portfolio item number 2
publications
Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies.
Published in Cell Stem Cell, 2018
Here we reviewed the mutations associatd with clonal hematopoiesis, how they influence evolution to malignancy, and how mutant clones non hematological disease progression.
Recommended citation: Bowman RL, Busque L, Levine RL. Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies." Cell Stem Cell. 2018 Feb 1;22(2):157-170.
Cohesin Members Stag1 and Stag2 Display Distinct Roles in Chromatin Accessibility and Topological Control of HSC Self-Renewal and Differentiation.
Published in Cell Stem Cell, 2019
Here we investiagated the role of Stag2 and Stag1 knockouts on hematopoietic function.
Recommended citation: Viny AD, Bowman RL, Liu Y, Lavallée VP, Eisman SE, Xiao W, Durham BH, Navitski A, Park J, Braunstein S, Alija B, Karzai A, Csete IS, Witkin M, Azizi E, Baslan T, Ott CJ, Peer D, Dekker J, Koche R, Levine RL. "Cohesin Members Stag1 and Stag2 Display Distinct Roles in Chromatin Accessibility and Topological Control of HSC Self-Renewal and Differentiation." Cell Stem Cell. 2019 Nov 7;25(5):682-696.e8.
Single-cell mutation analysis of clonal evolution in myeloid malignancies
Published in Nature, 2020
In this manuscript we utilize single cell DNA-sequencing to evaluate clonal abundance and mutation order in patient samples ranging from clonal hematopoiesis to relapsed/refractory leukemia. We combined scDNA-seq with oligonucleotide conjugated antibodies to resolve how genotype influences differentiation/immunophenotype.
Recommended citation: Miles LA*, Bowman RL*, Merlinsky TR, Csete IS, Ooi AT, Durruthy-Durruthy R, Bowman M, Famulare C, Patel MA, Mendez P, Ainali C, Demaree B, Delley CL, Abate AR, Manivannan M, Sahu S, Goldberg AD, Bolton KL, Zehir A, Rampal R, Carroll MP, Meyer SE, Viny AD, Levine RL. "Single-cell mutation analysis of clonal evolution in myeloid malignancies." Nature. 2020 Nov;587(7834):477-482.
Modeling clonal evolution and oncogenic dependency in vivo in the context of hematopoietic transformation
Published in Preprint-biorxiv, 2022
In this manuscript we develop tools for inducing up to three sequential mutations in mice for model the evolution from clonal hematopoiesis to acute myeloid leukemia. In order to investigate oncogene dependency, further develop tools to turn on a mutant oncogene, and subsequently revert that mutation.
Recommended citation: Robert L. Bowman, Andrew Dunbar, Tanmay Mishra, Wenbin Xiao, Michael R. Waarts, Inés Fernández Maestre, Shira E. Eisman, Louise Cai, Sheng F. Cai, Pablo Sanchez Vela, Shoron Mowla, Anthony R. Martinez Benitez, Young Park, Isabelle S. Csete, Aishwarya Krishnan, Darren Lee, Nayla Boorady, Chad R. Potts, Matthew T. Jenkins, Martin P. Carroll, Sara E. Meyer, Linde A. Miles, P. Brent Ferrell Jr., Jennifer J. Trowbridge, Ross L. Levine. Modeling clonal evolution and oncogenic dependency in vivo in the context of hematopoietic transformation. bioRxiv 2022.05.18.492524; doi: https://doi.org/10.1101/2022.05.18.492524
Jak2V617F Reversible Activation Shows an Essential Requirement for Jak2V617F in Myeloproliferative Neoplasms
Published in Preprint-biorxiv, 2022
In this manuscript we developed a reversible JAK2V617F model with Dre->Cre functionality, such that the Cre sites which delete/reverse JAK2V617F are only available after Dre recombination induces mutant expression. This allowed us to test the dependency of JAK2-mutations in propagating myeloproliferative disease.
Recommended citation: Andrew Dunbar, Robert L. Bowman, Young Park, Franco Izzo, Robert M. Myers, Abdul Karzai, Won Jun Kim, Inés Fernández Maestre, Michael R. Waarts, Abbas Nazir, Wenbin Xiao, Max Brodsky, Mirko Farina, Louise Cai, Sheng F. Cai, Benjamin Wang, Wenbin An, Julie L Yang, Shoron Mowla, Shira E. Eisman, Tanmay Mishra, Remie Houston, Emily Guzzardi, Anthony R. Martinez Benitez, Aaron Viny, Richard Koche, Dan A. Landau, Ross L. Levine. Jak2V617F Reversible Activation Shows an Essential Requirement for Jak2V617F in Myeloproliferative Neoplasm. bioRxiv 2022.05.18.492332; doi: https://doi.org/10.1101/2022.05.18.492332
talks
Talk 1 on Relevant Topic in Your Field
Published:
This is a description of your talk, which is a markdown files that can be all markdown-ified like any other post. Yay markdown!
Conference Proceeding talk 3 on Relevant Topic in Your Field
Published:
This is a description of your conference proceedings talk, note the different field in type. You can put anything in this field.
teaching
Teaching experience 1
Undergraduate course, University 1, Department, 2014
This is a description of a teaching experience. You can use markdown like any other post.
Teaching experience 2
Workshop, University 1, Department, 2015
This is a description of a teaching experience. You can use markdown like any other post.